James F. Oliviero III, CEO, President and Director at Checkpoint Therapeutics, Inc. (CKPT), sold 504,000 shares at $1.09 ($550K) on 2022-06-17, disclosed to the SEC on 2022-07-01.
Open-market sale of $550k CKPT by CEO, President and Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.09 | 228,000 | $249K | 45.2% |
| 2 | $1.09 | 228,000 | $249K | 45.2% |
| 3 | $1.09 | 21,000 | $23K | 4.2% |
| 4 | $1.09 | 12,000 | $13K | 2.4% |
| 5 | $1.11 | 15,000 | $17K | 3.0% |
| Total | $1.09 avg | 504,000 |
| $550K |
| 100% |
| Filing → |
| CKPT | SELL | 2024-12-20 | $6.1M | — | Filing → |
| CKPT | SELL | 2024-06-28 | $101K | — | Filing → |
| CKPT | SELL | 2024-03-01 | $12K | — | Filing → |